If you suffer from migraines and have been diagnosed with severe headaches, it may be of interest to you to know the benefits of CBD oil for symptom relief. Migraine is a chronic disease neurological condition that shares common features with other chronic conditions where cannabidiol can improve quality of life.
These common features include the need for palliative treatments that do not cure the disease but rather alleviate symptoms, the use of anti-inflammatory and analgesic drugs, and the presence of chronic pain associated with soft tissue inflammation.
Having a migraine diagnosed does not simply mean having an occasional headache. Rather, it falls into one of two categories:
- Episodic migraineYou experience disabling headaches that last between 1 and 9 days per month.
- Chronic migraineSevere headaches occur for more than 15 days per month and have a significant impact on quality of life.
Migraines, types and symptoms.
In addition to the two levels of the disease, there are two types of migraine:
- Migraine without auraIn this type of migraine, the patient experiences a severe headache with no other associated symptoms. However, sometimes a heartbeat can be felt in the head, known as throbbing pain, which increases anxiety in sufferers.
- Migraine with auraIn this type of migraine, the severe headache is accompanied by symptoms that affect sight, touch and/or speech. These may include flashes of light in the field of vision, tingling in different parts of the body and even speech difficulties.
It is estimated that between 15% and 30% of people with migraine suffer from migraines with aura. In Spain, an estimated 4 million people are affected by migraines, representing 8.5% of the population. Migraine is a common disease that affects women in 80% of cases.
What causes migraines?
Migraine is caused by abnormal brain activity, although the exact chain of events that triggers it is still unclear and is the subject of ongoing research. Most medical experts believe that the attack begins in the brain and affects nerve and chemical pathways. These changes can alter blood flow in the brain and surrounding tissues.
Migraines tend to appear for the first time between the ages of 10 and 45, although in some cases they may start earlier or later in life. Migraine can have a hereditary component and affects women more often than men. Some women experience fewer migraines during the pregnancyThis is not true in all cases, however.
There are several causes that can trigger a migraine attack, including:
- Caffeine withdrawal.
- Hormonal changes during a woman's menstrual cycle or the use of birth control pills.
- Alterations in sleep patterns, such as lack of rest.
- Alcohol consumption.
- Exercise or intense physical stress.
- Exposure to loud noises or bright lights.
- Fasting or skipping meals.
- Intense scents and perfumes.
- Tobacco or smoke exposure.
- Stress and anxiety.
In addition, certain food can also trigger migraines, for example:
- Dairy products, especially certain types of cheese.
- Food containing monosodium glutamate (MSG).
- Foods containing tyramine, such as red wine, some types of cheese, smoked fish, chicken livers, figs and some legumes.
- Fruits such as avocado, banana and citrus fruits.
- Meats containing nitrates, such as bacon, sausages, salami and cured meats.
- Peanuts and other nuts and seeds.
- Processed, fermented, marinated or pickled foods.
Living with migraines means dealing with a chronic disease for which there is no cure, and the focus of treatment is on improving the patient's quality of life. Conventional treatment involves the use of painkillers and anti-inflammatory drugs, but CBD is being investigated as a promising complementary therapy.
Benefits of CBD for migraines
The CBD oil is gaining popularity as an adjunctive treatment for neurological diseases due to its anti-inflammatory effect. In the case of migraines, a process occurs that involves more vasodilation than normal, causing swelling of the brain and pain due to pressure between the skull and the brain. Vasodilation can also cause oedema which contributes to the sensation of pain.
The CBD oil can help to slow down this process of inflammation and oedema, which reduces the frequency and intensity of migraines. By addressing the underlying biological process, the effect of the treatment can be longer lasting than traditional painkillers, which only temporarily relieve the pain. pain.
CBD alternatives to treat migraines
Research is currently underway on the effects of cannabidiol (CBD)CBD, a cannabis compound, as a complementary treatment for migraine. CBD is known for its anti-inflammatory, analgesic and neuroprotectiveand so it is believed that it can help to reduce the symptoms of the migraines.
It has been found that the CBD oils can help reduce the frequency and intensity of migraine attackswhile at the same time improve the quality of sleep y reduce anxiety associated with this condition. CBD may also help reduce inflammation in the brain, which may be one of the underlying causes of migraines.
It is important to note that the dosage and method of administration of CBD may vary depending on the individual and the severity of their condition. In addition, It is essential that patients consult with a healthcare professional before starting any CBD treatment to ensure that it is safe and effective for their particular case.
Scientific studies: CBD oil and migraines
There are currently some clinical trials underway to evaluate the effectiveness of CBD oil in the treatment of migraines.
For example, a study published in 2020 in the journal Frontiers in Neurology evaluated the effects of CBD oil in 48 patients with chronic migraines. Participants received a daily dose of 200 mg CBD oil for three months. The results indicated that CBD oil significantly reduced the frequency of migraine attacks as well as the intensity of pain.
Another ongoing study is a clinical trial randomised, placebo-controlled trial assessing the effect of the CBD oil in patients with chronic migraines. This study aims to recruit 140 participants and evaluate the optimal dose of CBD oil and its effectiveness in reducing the frequency and intensity of migraine attacks.
It is important to note that more studies are still needed to determine the effectiveness and safety of the CBD oil in the treatment of migraines. In addition, other factors such as appropriate dosage and possible side effects should be considered.
It is therefore important that patients who wish to use CBD oil to treat their migraines consult with their doctor before beginning any treatment.
How many drops of CBD oil should I apply for migraine?
Although the dosage of CBD oil is something that varies greatly from person to person, there is a set optimal dosage for each person to use, and the way to know this is to start with a minimum amount (about 10 mg CBD spread over 3 uses per day) and gradually increase (e.g. about 10 mg of CBD every 2 or 3 days depending on the response) until the effect is noticeable.
*This article is for information purposes only. We do not provide professional, medical or pharmaceutical advice. Our CBD products are for external use only. Bove Health (Dermo Biotech SL) accepts no liability for any inconvenience or damage resulting from the use of the information presented here. Our texts are in no way a substitute for the professional advice of a doctor or pharmacist and cannot be used as a basis for independent diagnosis and initiation, modification or termination of treatment of diseases. If you have questions or complaints about your health, always consult a doctor you trust. The contents of this site have been created with the greatest possible care and serve exclusively for information and further education on the subject. However, Bove Health assumes no liability for the accuracy, topicality and completeness of the texts and contents provided. They do not represent a recommendation of the diagnostic methods, treatments or medications described or mentioned and are not intended to serve as advertising. Bove Health is not subject to the control procedure according to article 27 VO 834/2007.